RxDoctor Payments Data

Alexandra Erhardt, DO

General Surgery · Hackensack, NJNPI 1861853343

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.5%), food and beverage and education — rather than concentrated in one kind of arrangement. Integra Lifesciences Corporation accounts for 63.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $1,610 and has fallen 81.2% since, to $302 in 2025.

$2,225in general payments, 2019–2025

Across 29 payments — averaging $76.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$1K
  • AstraZeneca$314
  • Sanofi-aventis U.S. LLC$185
  • AbbVie$126
  • Astellas Pharma US Inc$64
  • Smith+Nephew$47
  • plus $79 from 3 others

What the payments were for

  • Travel & lodging$1,21254%
  • Food & beverage$82837%
  • Education$1858%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,225 in reported general payments places this provider in the 75th percentile of 39 general surgery providers in New Jersey.

See all general surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$135,021
Medicare patients
151
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl91$20,039
EliquisApixaban19$11,141
Nifedipine ErNifedipine64$779
Nystatin18$698
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim118$562
Cinacalcet Hcl13$319
Hydralazine Hcl22$311
Prednisone54$279
Calcitriol18$266
Potassium Chloride12$250
Pantoprazole Sodium39$227
Tamsulosin Hcl31$189
Carvedilol26$160
Acetaminophen-CodeineAcetaminophen With Codeine19$131
Furosemide28$109

Paid to pharmacies, not to this prescriber.

Other general surgery in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →